Experimental group:Bendamustine plus melphalan

2 trials

Sponsors

The Department of Hematology of the Affiliated Hospital of Southwest Medical University, The Department of Hematology, West China Hospital, Sichuan University

Conditions

Multiple meyloma

Phase 4

The efficacy on the combination of bendamustine with melphalan as autologous hematopoietic stem cell transplantation conditioning regimen in multiple myeloma

RecruitingChiCTR2100046675

The Department of Hematology of the Affiliated Hospital of Southwest Medical UniversityMultiple meyloma

Start: 2021-06-01Updated: 2022-01-04

The efficacy on the combination of bendamustine with melphalan as autologous hematopoietic stem cell transplantation preconditioning regimen in multiple myeloma.

Active, not recruitingChiCTR2100048305

The Department of Hematology, West China Hospital, Sichuan UniversityMultiple meyloma

Start: 2021-07-05Updated: 2022-03-14